More recently, Chen et al. detected IDH1 mutations in CSF‐derived EVs of patients with IDH‐mutant gliomas using highly sensitive techniques; conversely, serum‐derived EVs of the same patients were negative 68. This evidence concerns the gene IDH1 and central nervous system cancer.